Application of dermastin a in the preparation of preparations for suppressing immune rejection of organ transplantation
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- XUZHOU MEDICAL COLLEGE
- Publication Date
- 2016-11-16
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of organ transplant medicines, in particular to a new application of dermatoxin A (HyderminA, HA), which can reduce organ transplant rejection and provide a new method for allogeneic organ transplantation. Background technique
[0002] Organ transplantation is the main method for treating chronic end-stage diseases such as liver, kidney and heart, and suppression of rejection is one of the key factors restricting the long-term survival of transplanted organs. Parasites can invade hosts with normal immune function, and can evade the host's immune effects, develop, reproduce, and survive. This phenomenon is called immune evasion. Psoriasis larvae can migrate in the host tissue for 8 months, and the four serine proteases dermatoxin A, B, C, and D secreted by it have an immunosuppressive effect on the host, so that the host cannot use the immune function to kill the fly larvae. The immunoregulatory function of HA suppres...